1. Home
  2. XTNT

XTNT

Xtant Medical Holdings Inc.

Logo Xtant Medical Holdings Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Founded: N/A Country:
United States
United States
Employees: N/A City: BELGRADE
Market Cap: 109.0M IPO Year: N/A
Target Price: $1.60 AVG Volume (30 days): 154.4K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.01 EPS Growth: N/A
52 Week Low/High: $0.58 - $1.45 Next Earning Date: 05-02-2024
Revenue: $91,303,000 Revenue Growth: 57.50%
Revenue Growth (this year): 28.47% Revenue Growth (next year): 13.35%

Share on Social Networks: